Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» India
India
OrbiMed lines up $551M gamble on China, India biotech sectors
Endpoints
Tue, 09/5/17 - 11:03 am
OrbiMed
China
India
biotech
venture capital
With U.S. Generic Drug Market in Chaos, Indian Upstarts Rise
Bloomberg
Thu, 08/31/17 - 12:06 pm
generics
India
Pfizer Wins Indian Patent on Prevnar 13 Vaccine
RAPS.org
Tue, 08/22/17 - 06:43 pm
Pfizer
India
Prevnar 13
vaccine
patents
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Mon, 08/14/17 - 10:04 am
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
Mass Device
Tue, 07/18/17 - 09:24 am
FDA
India
clinical trials
FDA Collaborates to Promote Safety, Quality in Clinical Trials Done in India
FDA Voice
Wed, 07/12/17 - 02:44 pm
FDA
India
clinical trials
Indian drugmaker stages worker strike to avoid FDA inspection
BioPharma Dive
Thu, 05/11/17 - 06:21 pm
India
FDA
inspection
warning letter
The Billionaire And The Drug Price-Fixing Scandal
Forbes
Tue, 04/18/17 - 09:33 am
price fixing
India
Heritage Pharmaceuticals
Emcure
FDA jumps on another Mylan plant in India, slapping it with a warning letter
Fierce Pharma
Wed, 04/12/17 - 11:01 am
FDA
drug manufacturing
India
Mylan Labs
India Authorized Agent Role Changes under New Medical Device Rules
Emergo
Tue, 03/28/17 - 10:19 am
India
devices
As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
Fierce Pharma
Sat, 03/11/17 - 11:55 am
Bayer
intellectual property
India
exporting
Xarelto
Nexavar
India wants to sell low-cost drugs in Trump’s America, but quality questions persist
Fierce Pharma
Sun, 03/5/17 - 12:23 pm
India
drug manufacturing
Abbott denies reports it will bail on India’s high-end stent market
Mass Device
Wed, 02/22/17 - 09:55 am
Abbott Labs
India
coronary stents
devices
New medical device rules from Indian regulators
Mass Device
Mon, 02/6/17 - 11:11 am
devices
India
regulatory
India is now classifying dozens of drug makers as high-risk
Stat/Pharmalot
Wed, 11/30/16 - 10:05 am
India
compliance
A day in the life of a drug rep in India
Thu, 10/27/16 - 04:01 pm
Piramal picks up J&J drugs in strategic move
BioPharma Dive
Wed, 10/12/16 - 11:32 am
Piramal Healthcare
India
JNJ
Sublimaze
Sufenta
Dipidolor
Rapifen
Hypnomidate
Dr Reddy's and Amgen broaden marketing collaboration
BioPharma Dive
Tue, 09/20/16 - 09:51 am
Amgen
Dr Reddy's
India
Xgeva
Prolia
Vectibix
Sun Pharma's ex-Ranbaxy sales reps threaten all-India strike against new policies
Fierce Pharma
Tue, 09/13/16 - 09:46 am
Sun Pharma
Ranbaxy
India
drug reps
FDA renews ban on Indian drugmaker after fresh violations
BioPharma Dive
Thu, 09/8/16 - 06:33 pm
FDA
India
Pan Drugs
drug manufacturing
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »